Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Toxic Substances Act overhaul proposed

This article was originally published in The Tan Sheet

Executive Summary

Sen. Frank Lautenberg, D-N.J., chairman of the Subcommittee on Environmental Health, introduces legislation to overhaul the Toxic Substances Control Act, and House Energy and Commerce Committee Chairman Henry Waxman, D-Calif., and Rep. Bobby Rush, D-Ill., release a discussion draft of legislation on tightening control of toxic chemicals. The existing law is "riddled with so many loopholes that in more than 30 years, the Environmental Protection Agency has been able to regulate only five of the 83,000 chemicals in use in consumer goods," the Environmental Working Group said in an April 15 release. Lautenberg's Safe Chemicals Act, S. 3209, would require chemical manufacturers to prove products are safe in order to keep them on the market. The legislation also would require EPA to establish an interagency panel to select a priority list of 300 chemicals for regulatory review

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104027

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel